PC
Insider
Patricia Carr
SVP, Chief Accounting OfficerPatricia Carr (SVP, Chief Accounting Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $956K of JAZZ (5,250 sh × $182.07, as filed), executed Nov 18 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.4M
shares × price, as filed
Last traded
Mar 9
Filed Mar 9
Median ADV $210.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
JAZZRecent filings
JAZZSALE
Jazz Pharmaceuticals plc
View filing →
$235K1,287 sh × $182.94
Exec Mar 9
Filed Mar 9 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc View filing → $456K
2,370 sh across 2 lots
Exec Feb 26
Filed Mar 2 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc View filing → $770K
4,500 sh × $171.20
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc View filing → $956K
5,250 sh × $182.07
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc View filing → $157K
1,140 sh × $137.81
Exec Mar 10 2025
Filed Mar 11 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc View filing → $761K
5,273 sh across 2 lots
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET